Reconstitution of EBV-specific T-cell memory and control of PTLD after transfer of peptide-selected T-cells

被引：0
|
作者：
Moosmann, A. [1 ]
Tischer, J. [1 ]
Schirrmann, L. [1 ]
Kasten, J. [2 ]
Tippmer, S. [2 ]
Bigalke, I. [2 ]
Kolb, H. -J. [1 ]
机构：
[1] Univ Munich, Munich, Germany
[2] Helmholtz Zentrum, Munich, Germany
来源：
BONE MARROW TRANSPLANTATION | 2010年 / 45卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S212 / S212
页数：1
相关论文
共 50 条
  • [21] Phenotypic and functional analysis of EBV-specific memory CD8 T-cells in SLE patients.
    Berner, BR
    Ott, PA
    Lehmann, PV
    Tary-Lehmann, M
    Anthony, DD
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S196 - S196
  • [22] Adoptive immunotherapy of EBV-associated malignancies with EBV-specific cytotoxic T-cell lines
    Rooney, CM
    Aguilar, LK
    Huls, MH
    Brenner, MK
    Heslop, HE
    EPSTEIN-BARR VIRUS AND HUMAN CANCER, 2001, 258 : 221 - 229
  • [23] Dissecting Epstein-Barr Virus-Specific T-Cell Responses After Allogeneic EBV-Specific T-Cell Transfer for Central Nervous System Posttransplant Lymphoproliferative Disease
    Schultze-Florey, Rebecca E.
    Tischer, Sabine
    Kuhlmann, Leonie
    Hundsdoerfer, Patrick
    Koch, Arend
    Anagnostopoulos, Ioannis
    Ravens, Sarina
    Goudeva, Lilia
    Schultze-Florey, Christian
    Koenecke, Christian
    Blasczyk, Rainer
    Koehl, Ulrike
    Heuft, Hans-Gert
    Prinz, Immo
    Eiz-Vesper, Britta
    Maecker-Kolhoff, Britta
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [24] DEFECTIVE EBV-SPECIFIC SUPPRESSOR T-CELL FUNCTION IN RHEUMATOID-ARTHRITIS
    TOSATO, G
    STEINBERG, AD
    BLAESE, RM
    NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (21): : 1238 - 1243
  • [25] Autologous EBV-specific cytotoxic T cells to treat EBV-associated post-transplant lymphoproliferative disease (PTLD).
    Comoli, P
    Locatelli, F
    Gerna, G
    Grossi, P
    Vigano, M
    Maccario, R
    BLOOD, 1997, 90 (10) : 1097 - 1097
  • [26] Characterization of αβ AND γδ T cells in clinical-grade EBV-specific T-cell products and their role in controlling EBV infection in allogeneic and autologous settings
    Mausberg, Philip
    Bonifacius, Agnes
    Tischer-Zimmermann, Sabine
    Santamorena, Maria Michela
    Dragon, Anna Christina
    Blasczyk, Rainer
    Ravens, Sarina
    Maecker-Kolhoff, Britta
    Eiz-Vesper, Britta
    HLA, 2022, 99 (05) : 474 - 475
  • [27] Characterization of αβ and γδ T cells in clinical-grade EBV-specific T-cell products and their role in controlling EBV infection in allogeneic and autologous settings
    Mausberg, P.
    Bonifacius, A.
    Tischer-Zimmermann, S.
    Santamorena, M. M.
    Dragon, A. C.
    Rahmati, P.
    Blasczyk, R.
    Ravens, S.
    Maecker-Kolhoff, B.
    Eiz-Vesper, B.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2022, 52 : 363 - 364
  • [28] IMMUNE ESCAPE BY EPSTEIN-BARR-VIRUS (EBV) CARRYING BURKITTS-LYMPHOMA - INVITRO RECONSTITUTION OF SENSITIVITY TO EBV-SPECIFIC CYTOTOXIC T-CELLS
    MASUCCI, MG
    ZHANG, QJ
    GAVIOLI, R
    DECAMPOSLIMA, PO
    MURRAY, RJ
    BROOKS, J
    GRIFFIN, H
    PLOEGH, H
    RICKINSON, AB
    INTERNATIONAL IMMUNOLOGY, 1992, 4 (11) : 1283 - 1292
  • [29] REGULATORY T-CELLS REQUIRING PRESENTATION OF T-CELL RECEPTOR PEPTIDE BY ENCEPHALITOGENIC T-CELLS
    KOZOVSKA, M
    YAMAMURA, T
    TABIRA, T
    NEUROLOGY, 1994, 44 (04) : A243 - A243
  • [30] In vivo expansion of LMP 1-and 2-specific T-cells in a patient who received donor-derived EBV-specific T-cells after allogeneic stem cell transplantation
    Bollard, Catherine M.
    Gottschalk, Stephen
    Huls, M. Helen
    Molldrem, Jeffrey
    Przepiorka, Donna
    Rooney, Cliona M.
    Heslop, Helen E.
    LEUKEMIA & LYMPHOMA, 2006, 47 (05) : 837 - 842
12345